15 June 2020 : Clinical Research
Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis
Sikai Nong1BCD, Xinbin Pan1BCD, Kaihua Chen1EF, Ye Li1CD, Xiaodong Zhu1AFG*DOI: 10.12659/MSM.922244
Med Sci Monit 2020; 26:e922244
Table 4 OS rates in the 2 patient groups.
| Group | N | OS(%) | P-value | ||
|---|---|---|---|---|---|
| 1-year | 2-year | 3-year | |||
| <6-cycle | 29 | 64.8% | 34.3% | 17.2% | 0.042 |
| ≥6-cycle | 29 | 92.6% | 54.9% | 30.9% | |